(Reuters) - The U.S. Food and Drug Administration said on Wednesday that it had approved Pfizer Inc's drug, Xeljanz, to treat adults with moderate-to-severe active ulcerative colitis.
from Reuters: Health News https://ift.tt/2IW7ovD
via IFTTT
from Reuters: Health News https://ift.tt/2IW7ovD
via IFTTT
Post a Comment